Why COVID-19 survivors struggle to breathe: muscle damage revealed
NCT ID NCT04854863
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at breathing muscle function in 50 people who were hospitalized for COVID-19. Half had been on a ventilator, half only needed extra oxygen. Researchers used advanced tests to measure diaphragm strength and movement. The goal was to understand why many survivors feel tired and short of breath, and to guide future rehabilitation programs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that dedicated breathing-muscle training helps COVID-19 survivors recover from fatigue and shortness of breath.
- What could go wrong
- This is a small, observational study with only 50 participants. It measures muscle function but does not test any treatment, so it cannot prove that rehabilitation works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jens Spiesshoefer
Aachen, North Rhine-Westphalia, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a different way of pedaling rebuild muscles after severe COVID-19?
- Ancient herbs take on long COVID: a trial tests whether chinese medicine can soothe persistent fatigue
- Can a 15-Minute chat at a testing site boost COVID-19 vaccination?
- E-Ink screens in ERs could boost patient satisfaction
- Massive study tracks how lockdowns shaped mental health across america
- Hidden danger: study probes blood clot risk in cancer patients with COVID-19